Zorubicin

This classification denotes an anthracycline antibiotic with the molecular formula C34H35N3O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V25F9362OP, chemically known as rp-22,050 hydrochloride but generally known as zorubicin, which bears US NIH Compound Identifier 6540456. European Medicines Agency schedules Zorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00190MIG. The term ZORUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules zorubicin in its Anatomical Therapeutic Chemical (ATC) Classification. ZORUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zorubicin under HS 29419000 and SITC 54139. As of Q4 2014, ZORUBICIN remains the US FDA Preferred Term for this commodity. Zorubicin bears US NLM identifiers UMLS ID CL421815 and NCI Concept Code C91365. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)C(OC)CCC2)/C(=N/NC(=O)C1CCCCC1)C)C1OC(C(O)C(N)C1)C.